IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Cash from Investing Activities (2018 - 2026)

Updated

IRulya Therapeutics (IRLA) reported Cash from Investing Activities of $8 million for Q2 2026, up 32.5% from $6.04 million a year earlier but down 33.3% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, IRulya Therapeutics' Cash from Investing Activities came in at $26.29 million, down 24.7% year-over-year; for FY2025, it came in at $23.23 million, up 6.0% from FY2024.

  • By year, Cash from Investing Activities came in at $21.91 million in FY2024, -$5.76 million in FY2023, $18 million in FY2022 (-69.5%) and $58.95 million in FY2021.
  • Five-year quarterly Cash from Investing Activities spans a low of -$20.32 million in Q2 2023 and a high of $20.92 million in Q4 2021.
  • Year over year, Cash from Investing Activities gained in five of the last six quarters, with growth averaging 39.4%.
  • The high point for year-over-year Cash from Investing Activities in five years was Q4 2024 (growth of 101.6%); the low point was Q3 2021 (a decline of 92.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $12 million (Q1 2026), $8.07 million (Q4 2025) and -$1.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -2.71 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -10.22 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -244.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -2.03 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - 8.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.00 Mn
Mar 31, 2026 12.00 Mn
Dec 31, 2025 8.07 Mn
Sep 30, 2025 -1.78 Mn
Jun 30, 2025 6.04 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 10.87 Mn
Sep 30, 2024 7.11 Mn
Jun 30, 2024 -4.98 Mn
Mar 31, 2024 8.91 Mn
Dec 31, 2023 5.39 Mn
Sep 30, 2023 3.64 Mn
Jun 30, 2023 -20.32 Mn
Mar 31, 2023 5.54 Mn
Dec 31, 2022 18.67 Mn
Sep 30, 2022 -8.83 Mn
Jun 30, 2022 -5.25 Mn
Mar 31, 2022 13.41 Mn
Dec 31, 2021 20.92 Mn
Sep 30, 2021 766,000.00
API Access

IRulya Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=IRLA&period=max&api_key=YOUR_API_KEY